Loading...
DOCUMENTS
74
NOTICES
154
MOTS CLES
Anticancer drugs
Antimicrobial resistance
Stability
Auto-immune hepatitis
Biological therapy
Cardiovascular risk
Placebo
Alitretinoin
Aging
Adverse side effects
Cessation
Endocrine toxicity
Addiction
Management
Angiotensin-converting enzyme inhibitors
Acute Myeloid Leukaemia AML
Biologic therapy
Antibiotic misuse
Bacterial rhinosinusitis
Auto-Diagnostic
Cardiotoxicity
Adolescent
Autoimmunity
Intensive care
Angiotensin receptor blockers
Anti-TNF
Biologics
Sipuleucel-T
Antibiotics
CTLA-4
Case-Control Studies
Access to care
Albinism
Méta-Analyse
Abus d'antibiotiques
Calcium channel blockers
Atrial fibrillation
Glucocorticoids
Immune-related adverse events
Graft-versus-host disease
Burden
Beta-lactam antibiotics
Cardio-oncology
Primary adrenal insufficiency
Spondyloarthritis
Apre-milast
Azathioprine
Atopic dermatitis
Infliximab
Biomarkers
Apremilast
COVID-19
Causality
BTK protein
Biologic
Ankylosing spondylitis
Adalimumab
Drug reaction
Antimicrobiens
ASDAS
Epidemiology
Cancer
Cardiovascular therapy
Cardiomyopathy
Chemotherapy
Arrhythmia
Cessation aids
Cattle
Anti-HCV Direct Acting Antivirals DAA
Axial spondyloarthritis
Vigibase®
Arthritis
Antimicrobials
Quality of life
Care pathway
Pharmacovigilance
Ustekinumab
Psoriasis
Etanercept
Accelerometer
Prostate cancer
Amyloidosis
Antibiotic resistance
Pharmacoepidemiology
Immune checkpoint inhibitors
Dermatology
ArtThese
Biologic drug
CSK tyrosine-protein kinase
Ethics
Psoriatic arthritis
Causality Background
Meta-Analysis
Alcohol
Sacroiliitis
Autoimmune diseases
Immunotherapy
Biomédicaments
Drug survival
Treatment
Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379 | |
---|---|
Adresse |
Université Paris-Est Créteil Val de Marne (UPEC) Campus Centre de Créteil |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Émilie SBIDIAN |
Axe(s) de recherche
|
|
COLLABORATIONS
|